90 related articles for article (PubMed ID: 8136264)
1. Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation.
Borset M; Helseth E; Naume B; Waage A
Br J Haematol; 1993 Nov; 85(3):446-51. PubMed ID: 8136264
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
[TBL] [Abstract][Full Text] [Related]
3. Isolation of bone marrow plasma cells by negative selection with immunomagnetic beads.
Fillola G; Muller C; Bousquet R; Fontanilles AM; Laharrague P; Corberand JX
J Immunol Methods; 1996 Mar; 190(1):127-31. PubMed ID: 8601705
[TBL] [Abstract][Full Text] [Related]
4. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.
Yamamoto I; Kawano M; Sone T; Iwato K; Tanaka H; Ishikawa H; Kitamura N; Lee K; Shigeno C; Konishi J
Cancer Res; 1989 Aug; 49(15):4242-6. PubMed ID: 2787204
[TBL] [Abstract][Full Text] [Related]
5. Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts.
Karadag A; Oyajobi BO; Apperley JF; Russell RG; Croucher PI
Br J Haematol; 2000 Feb; 108(2):383-90. PubMed ID: 10691869
[TBL] [Abstract][Full Text] [Related]
6. [Production of interleukin-1 and interleukin-6 in a culture of mononuclear cells of peripheral blood and bone marrow in multiple myeloma].
Kliushnenkova EN; Lutskaia TD; Golenkov AK; Malaĭtsev VV
Biull Eksp Biol Med; 1993 May; 115(5):507-10. PubMed ID: 8043836
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
8. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
9. Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting.
Cumova J; Kovarova L; Potacova A; Buresova I; Kryukov F; Penka M; Michalek J; Hajek R
Int J Hematol; 2010 Sep; 92(2):314-9. PubMed ID: 20694533
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of human multiple myeloma cell enriched populations.
Tai YT; Teoh G; Shima Y; Chauhan D; Treon SP; Raje N; Hideshima T; Davies FE; Anderson KC
J Immunol Methods; 2000 Feb; 235(1-2):11-9. PubMed ID: 10675753
[TBL] [Abstract][Full Text] [Related]
11. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
12. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
Thomas X; Anglaret B; Magaud JP; Epstein J; Archimbaud E
Leuk Lymphoma; 1998 Dec; 32(1-2):107-19. PubMed ID: 10037006
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
Kovacs E
Leuk Res; 2010 Jul; 34(7):912-6. PubMed ID: 19762082
[TBL] [Abstract][Full Text] [Related]
15. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma.
Lichtenstein A; Berenson J; Norman D; Chang MP; Carlile A
Blood; 1989 Sep; 74(4):1266-73. PubMed ID: 2475182
[TBL] [Abstract][Full Text] [Related]
16. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
Lu ZY; Bataille R; Poubelle P; Rapp MJ; Harousseau JL; Klein B
Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A; Grande A; Gamberi B; Bonsi L; Fogli M; Amabile M; Cavo M; Ferrari S; Tura S
Br J Haematol; 1994 Dec; 88(4):760-9. PubMed ID: 7529540
[TBL] [Abstract][Full Text] [Related]
18. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.
Bataille R; Barlogie B; Lu ZY; Rossi JF; Lavabre-Bertrand T; Beck T; Wijdenes J; Brochier J; Klein B
Blood; 1995 Jul; 86(2):685-91. PubMed ID: 7605999
[TBL] [Abstract][Full Text] [Related]
19. [Both myeloma cells and bone marrow stromal cells are involved in the overproduction of interleukin 6 in multiple myeloma].
Ding S; Hou J; Sun A
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):306-8. PubMed ID: 11243111
[TBL] [Abstract][Full Text] [Related]
20. Response patterns of purified myeloma cells to hematopoietic growth factors.
Anderson KC; Jones RM; Morimoto C; Leavitt P; Barut BA
Blood; 1989 May; 73(7):1915-24. PubMed ID: 2713508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
